Sonnet Biotherapeutics
Price & Volume
Stats
See more52W Range | $1.38-$18.71 |
Market Cap | $4.4M |
Shares Short | 115,614 |
Financials
See moreRevenue (12 Mos) | $1M |
Revenue Growth (YoY) | 5,268.8% |
Gross Profit (12 Mos) | -$351,390 |
Diluted EPS | -$10.45 |
News
See moreYahoo Finance • 3 days ago
Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates
Yahoo Finance • 4 days ago
Sonnet BioTherapeutics Selected for Poster Presentation at the 2025 AACR IO Conference
Yahoo Finance • 9 days ago
Sonnet BioTherapeutics Appoints Stephen McAndrew, Ph.D. as Chief Business Officer
Yahoo Finance • 9 days ago
Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update
About
CEO | Dr. Pankaj Mohan Ph.D. |
Address | 100 Overlook Center, Princeton, NJ, United States, 08540 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
